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Introduction
Most GP skin cancer training courses in Australia encourage beginners to use dermatoscopy algorithms when deciding if a lesion requires biopsy to exclude skin cancer. Indeed, the ability to recognise dermatoscopic criteria correctly and apply a dermatoscopic algorithm is often seen as the sine qua non of excellence in primary care skin cancer practice.
The benefits of using a scored "dermatoscopy-only" algorithm are well documented [1, 2] . However, this approach does not score often useful clinical information such as history of lesion change, the "ugly duckling" sign [3, 4] and even the patient's own instinct regarding the lesion. The authors feel that a more "holistic" diagnostic approach, where these clinical aspects are also scored, may reduce the chances of the student missing less obvious skin cancers.
Methods
We performed a retrospective analytical trial to see if a new algorithm, incorporating clinical as well as dermatoscopic criteria, was any different to the three methods commonly used in Australia primary care practice to diagnose skin cancer.
The new algorithm, BLINCK, was developed and compared to two "dermatoscopy-only" algorithms, (the 3-Point Checklist and the Menzies method), and clinical assessment alone.
The BLINCK algorithm was designed as an assessment tool for primary care skin cancer clinicians and does not require the user to be an "expert" in dermatoscopy. In contrast to most existing algorithms, the distinction between melanocytic and non-melanocytic [5] lesions is not necessary and both pigmented and non-pigmented lesions may be assessed. (Table 1) .
Four clinicians using four methods resulted in 16 contingency tables for sensitivity and specificity. As two of the methods related only to pigmented lesions, (3-Point and Menzies), the five non-pigmented specimens in the set of 50 were excluded from the contingency tables for these methods. Specificity, sensitivity and diagnostic accuracy were calculated according to standard formula. Analysis of variance (ANOVA) was used with the LSD test, (least significant difference test), to detect differences between clinicians and methods. A P-value of <0.05 indicated statistical significance.
The means for specificity, sensitivity and diagnostic accuracy are shown with their 95% Confidence Interval, (95% CI). We used the Statistica software package for statistical analysis.
Results
There were no differences between the clinicians regarding sensitivity, specificity, diagnostic accuracy, number of can- cers detected, number of melanomas found or biopsies indicated, however, there were significant differences between the four methods ( Table 2) . BLINCK had higher sensitiv- Table 3 .
Four clinically benign lesions were included in the set without a histological diagnosis, (dermatofibroma, seborrhoeic keratosis, congenital naevus and monitored flat naevus), and the remainder were subjected to histological examination (Table 4) .
Discussion
Australia has the highest rate of melanoma in the world [6] .
It is the third most common cancer in Australia in both men and in women [7] . Approximately two out of every three Australians will be diagnosed with skin cancer before the age of 70 [8] and roughly a million GP visits are made annually for skin cancer. This makes skin cancer the most expensive of all cancers for the Australian health system [9, 10] .
More skin cancers are diagnosed and treated in Australia by primary care doctors than by medical specialists [11] . These generalists require a simple yet accurate screening tool that will allow the detection of melanoma and other skin cancers at an early stage when complete cure is possible. Currently, most introductory skin cancer courses in Australia endorse dermatoscopic evaluation of suspicious skin lesions as the preferred screening method, commonly using the 3-Point checklist or the Menzies method [12, 13] .
Other clinical features that may assist with the diagnosis of skin cancer have been previously studied. The "ugly duck- ling" sign has been shown to be of possible use in melanoma screening [4] . Importantly, the ability to assess whether a lesion is "different" from surrounding lesions does not appear to require advanced training. Hence, it would seem sensible that primary care clinicians seek out "ugly duckling"
lesions when performing a skin examination, ("Lonely" in the BLINCK algorithm). Lesion change is also known to be associated with malignancy, particularly in patients over 50 years of age [14] , and consideration of this clinical feature would also seem prudent. A disproportionate amount of concern for a lesion by the patient, ("Nervous"), may have significance for two reasons. Firstly, patients may be uncertain if their lesion has changed or perhaps they may simply fail to volunteer the history of change, bleeding, itch or soreness. They suspect that it is a cancer but assume the doctor is able to make the diagnosis by mere inspection without needing any clinical history. However, this history may be the only clue to malignancy in dermatoscopically bland lesions, and a false negative diagnosis may be made using dermatoscopic assessment alone. Secondly, dismissing a lesion about which the patient is quite concerned may have medico-legal consequences should it prove later to be malignant.
In this small trial, the BLINCK algorithm, which scored these extra clinical features along with basic dermatoscopic assessment, found more skin cancers and melanomas than the commonly endorsed methods in Australia. However, more excisions were required to achieve this result. This raises the question as to what is the best measure of "accuracy" in melanoma diagnosis. Argenziano has suggested that NNE, (number of melanocytic lesions needed to be excised in order to find one melanoma), may be useful for measuring accuracy in melanoma detection and compared the NNE in specialised and non-specialised clinical settings [15] . In his study the NNE reduced over time from 12.8 to 6.8 with specialised clinics but remained unchanged at 29.4 in nonspecialised centres. This would seem to suggest that a level around 6.8 may be an appropriate goal for skin cancer clinicians. In our study, the overall NNE for melanoma by all clinicians using the BLINCK algorithm was 6, with the 3-Point checklist 11, the Menzies method 13 and clinical assessment only 22, suggesting that BLINCK may have value as a skin cancer screening tool.
As this trial was limited by the small number of skin cancers and melanomas, and by the fact that it was a vir- Regressed keratoacanthoma 1
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